eViralHepatitis Review
Volume 4, Issue 8, Part 1
May 26, 2015
High Efficacy of Sofosbuvir/Velpatasvir plus GS-9857 for 12 Weeks in Treatment-experienced Genotype 1-6 HCV-Infected Patients, Including those Previously Treated with Direct-acting Antivirals
New York
EViralHepatitis Review podcast channel
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast